A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Iris Schuiermanni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Macrolides, Clarithromycin, Mycobacterium avium Complex. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mycobacterium avium complex disease is difficult to treat, with high failure and recurrence rates despite multidrug, macrolide-based treatments. The bacterial mechanisms involved in this drug tolerance and persistence are incompletely understood. Recent evidence has suggested persistence through metabolic adaptations indicative of the viable but nonculturable state, including a decreased respiratory rate and a switch to lipid accumulation and metabolism. To assess the contribution of switching to viable but nonculturable state to macrolide tolerance, we performed time–kill kinetics assays for clarithromycin against M. avium . In these experiments, we performed Auramine-O (for acid-fastness, representing active mycobacteria) and Nile red (for lipid accumulation) staining and stimulation using resuscitation-promoting factors of Mycobacterium tuberculosis . Loss of auramine staining, increased Nile red staining and increased population sizes after stimulation with resuscitation-promoting factors support the hypothesis that clarithromycin induces a viable but nonculturable state in M. avium . Induction of a viable but nonculturable state is one of the mechanisms of macrolide tolerance in M. avium . It might be one of the drivers of the high failure and recurrence rates of macrolide-based treatments. Antimicrobials active against viable but nonculturable M. avium may improve treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
- Department of Medical Microbiology, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6710 HN, Ede, the Netherlands.
- Department of Microbiology, Paediatrics, Radiology and Public Health, Faculty of Medicine, University of Zaragoza, Zaragoza 50009, Spain.
- Department of Pulmonary Diseases, Radboudumc Community for Infectious Diseases, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, the Netherlands.
Zitieren
APA
Schuiermanni, I., Terschlüsen, E., de Man, H., Raaijmakers, J., Salillas, S., Schildkraut, J. A., & van Ingen, J. (2025). A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002072
Vancouver
Schuiermanni I, Terschlüsen E, de Man H, Raaijmakers J, Salillas S, Schildkraut JA, et al. A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002072
BibTeX
@article{Schuiermanni2025,
author = {Schuiermanni, Iris and Terschlüsen, Eva and de Man, Henrieke and Raaijmakers, Jelmer and Salillas, Sandra and Schildkraut, Jodie A and van Ingen, Jakko},
title = {A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002072}
}
EUVIMED